Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Optimization of a CE-ICP-MS/MS method for the investigation of liposome–cisplatin nanosystems and their interactions with transferrin

Anna Maria Wróblewska a, Jan Samsonowicz-Górski a, Ewelina Kamińska a, Marcin Drozd bc and Magdalena Matczuk *a
aChair of Analytical Chemistry, Faculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland. E-mail: magdalena.matczuk@pw.edu.pl; Tel: +48 222347719
bChair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland
cCentre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Poleczki Str. 19, 02-822 Warsaw, Poland

Received 6th February 2024 , Accepted 6th February 2024

First published on 12th February 2024


Abstract

Correction for ‘Optimization of a CE-ICP-MS/MS method for the investigation of liposome–cisplatin nanosystems and their interactions with transferrin’ by Anna Maria Wróblewska et al., J. Anal. At. Spectrom., 2022, 37, 1442–1449, https://doi.org/10.1039/D1JA00459J.


The authors regret that the sample loading described in Section 3.3 was incorrect. The correct sample loading was 350 mbar s, not 350 mbar × 5 s as originally published.

Additionally, the captions for Fig. 2 and 3 were accidentally reversed. The correct captions are shown below:


image file: d4ja90011a-f2.tif
Fig. 2 CE-ICP-MS/MS electropherogram of the E6 liposome–cisplatin systems; the grey dot-dashed lines correspond to free cisplatin (2), its hydrolyzed form (1), and the encapsulated liposome–cisplatin systems (3); voltage: +15 kV (current 3 mA), injection: 50 mbar 7 s, capillary: fused silica, length: 70 cm (i.d. 75 mm).

image file: d4ja90011a-f3.tif
Fig. 3 CE-ICP-MS/MS electropherogram of the E6 liposome–cisplatin–transferrin reaction mixture sample incubated for 20 h at 37C with stirring (400 rpm); the grey dot-dashed lines correspond to free cisplatin (2), its hydrolyzed form (1), the transferrin–cisplatin form (3), and encapsulated liposome–transferrin (4); voltage: +15 kV (current 3 mA), injection: 50 mbar 7 s, capillary: fused silica, length: 70 cm (i.d. 75 mm).

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2024
Click here to see how this site uses Cookies. View our privacy policy here.